Home/Filings/4/0001104659-26-002589
4//SEC Filing

MOULDER LEON O JR 4

Accession 0001104659-26-002589

CIK 0001953926other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 9:42 PM ET

Size

11.5 KB

Accession

0001104659-26-002589

Insider Transaction Report

Form 4
Period: 2026-01-07
MOULDER LEON O JR
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2026-01-07$16.38/sh+50,000$819,000316,155 total
  • Purchase

    Common Stock

    2026-01-08$16.30/sh+30,000$489,000346,155 total
  • Purchase

    Common Stock

    2026-01-09$16.55/sh+20,000$331,000366,155 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    36,928
  • Common Stock

    (indirect: See Footnote)
    1,672,039
Footnotes (5)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.21 to $16.53, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $15.82 to $16.60, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.05 to $16.87, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F4]The reporting person is a Trustee of the the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the "Trust") and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  • [F5]Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. Mr. Moulder disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Issuer

Zenas BioPharma, Inc.

CIK 0001953926

Entity typeother

Related Parties

1
  • filerCIK 0001228865

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 9:42 PM ET
Size
11.5 KB